These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 19825329

  • 21. Urinary lysophopholipids are increased in diabetic patients with nephropathy.
    Saulnier-Blache JS, Feigerlova E, Halimi JM, Gourdy P, Roussel R, Guerci B, Dupuy A, Bertrand-Michel J, Bascands JL, Hadjadj S, Schanstra JP.
    J Diabetes Complications; 2017 Jul; 31(7):1103-1108. PubMed ID: 28506691
    [Abstract] [Full Text] [Related]

  • 22. High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal Function.
    Triebel J, Moreno-Vega AI, Vázquez-Membrillo M, Nava G, García-Franco R, López-Star E, Baldivieso-Hurtado O, Ochoa D, Macotela Y, Bertsch T, Martinez de la Escalera G, Clapp C.
    Clin Lab; 2015 Jul; 61(7):709-16. PubMed ID: 26299069
    [Abstract] [Full Text] [Related]

  • 23. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M, Skupien J, Niewczas MA, Smiles AM, Doria A, Stanton RC, Galecki AT, Duffin KL, Pullen N, Breyer MD, Bonventre JV, Warram JH, Krolewski AS.
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [Abstract] [Full Text] [Related]

  • 24. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [Abstract] [Full Text] [Related]

  • 25. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS.
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [Abstract] [Full Text] [Related]

  • 26. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA, Tatsch E, Hausen BS, Bollick YS, Moretto MB, Duarte T, Duarte MM, Londero SW, Premaor MO, Comim FV, Delanghe JR, Moresco RN.
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [Abstract] [Full Text] [Related]

  • 27. Does dietary protein intake correlate with markers suggestive of early diabetic nephropathy in children and adolescents with Type 1 diabetes mellitus?
    O'Hayon BE, Cummings EA, Daneman D, Ossip MG, Lawson ML, Sochett EB.
    Diabet Med; 2000 Oct; 17(10):708-12. PubMed ID: 11110503
    [Abstract] [Full Text] [Related]

  • 28. Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus.
    Hirawa N, Uehara Y, Ikeda T, Gomi T, Hamano K, Totsuka Y, Yamakado M, Takagi M, Eguchi N, Oda H, Seiki K, Nakajima H, Urade Y.
    Nephron; 2001 Apr; 87(4):321-7. PubMed ID: 11287775
    [Abstract] [Full Text] [Related]

  • 29. Blood pressure changes and renal function in incipient and overt diabetic nephropathy.
    Mogensen CE, Christensen CK.
    Hypertension; 1985 Apr; 7(6 Pt 2):II64-73. PubMed ID: 3878334
    [Abstract] [Full Text] [Related]

  • 30. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.
    Mogensen CE, Christensen CK, Vittinghus E.
    Diabetes; 1983 May; 32 Suppl 2():64-78. PubMed ID: 6400670
    [Abstract] [Full Text] [Related]

  • 31. Urinary copper excretion in type 2 diabetic patients with nephropathy.
    Ito S, Fujita H, Narita T, Yaginuma T, Kawarada Y, Kawagoe M, Sugiyama T.
    Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
    Shen X, Zhang Z, Zhang X, Zhao J, Zhou X, Xu Q, Shang H, Dong J, Liao L.
    Lipids Health Dis; 2016 Oct 12; 15(1):179. PubMed ID: 27733168
    [Abstract] [Full Text] [Related]

  • 33. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC, Collaborative Study Group.
    Nephrology (Carlton); 2013 Jul 12; 18(7):516-24. PubMed ID: 23506627
    [Abstract] [Full Text] [Related]

  • 34. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C, Tarnow L, Goetze JP, Rossing P.
    Diabet Med; 2015 Mar 12; 32(3):374-81. PubMed ID: 25307511
    [Abstract] [Full Text] [Related]

  • 35. Glomerular charge and size selectivity assessed by changes in salt intake in type 2 diabetic patients.
    Yoshioka K, Imanishi M, Konishi Y, Sato T, Tanaka S, Kimura G, Fujii S.
    Diabetes Care; 1998 Apr 12; 21(4):482-6. PubMed ID: 9571328
    [Abstract] [Full Text] [Related]

  • 36. Effects of smoking and its cessation on creatinine- and cystatin C-based estimated glomerular filtration rates and albuminuria in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.
    Ohkuma T, Nakamura U, Iwase M, Ide H, Fujii H, Jodai T, Kaizu S, Kikuchi Y, Idewaki Y, Sumi A, Hirakawa Y, Kitazono T.
    Hypertens Res; 2016 Oct 12; 39(10):744-751. PubMed ID: 27250568
    [Abstract] [Full Text] [Related]

  • 37. Diurnal changes in urinary excretion of IgG, transferrin, and ceruloplasmin depend on diurnal changes in systemic blood pressure in normotensive, normoalbuminuric type 2 diabetic patients.
    Hosoba M, Fujita H, Miura T, Morii T, Shimotomai T, Koshimura J, Yamada Y, Ito S, Narita T.
    Horm Metab Res; 2009 Dec 12; 41(12):910-5. PubMed ID: 19670106
    [Abstract] [Full Text] [Related]

  • 38. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S, Haneda M, Koya D, Kondo K, Tanaka S, Arima H, Kume S, Nakazawa J, Chin-Kanasaki M, Ugi S, Kawai H, Araki H, Uzu T, Maegawa H.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2152-8. PubMed ID: 26563378
    [Abstract] [Full Text] [Related]

  • 39. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
    Kitai Y, Doi Y, Osaki K, Sugioka S, Koshikawa M, Sugawara A.
    Clin Exp Nephrol; 2015 Dec 07; 19(6):1037-43. PubMed ID: 25680889
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.